DISCOVERY LABS SAYS IT IS MAKING HEADWAY ON NEW DRUG

Discovery Laboratories Inc. said Tuesday it is making progress on its ongoing investigation into, and remediation efforts for, a problem that has delayed the approval of its lead new drug candidate Surfaxin.
Philadelphia Business Journal